Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)
China · Delayed Price · Currency is CNY 28.10
-1.25 (-4.26%)
At close: Feb 2, 2026
SHE:002773 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 1,250 | 1,191 | 1,045 | 896.67 | 421.08 | -269.85 |
Depreciation & Amortization | 230.41 | 230.41 | 222.6 | 158.27 | 149.38 | 118.5 |
Other Amortization | 3.98 | 3.98 | 3.72 | 4.57 | 2.44 | 3 |
Loss (Gain) From Sale of Assets | -0.01 | -0.01 | -0.01 | - | - | - |
Asset Writedown & Restructuring Costs | 2.19 | 2.19 | 1.35 | 0.68 | 215.06 | 1.76 |
Loss (Gain) From Sale of Investments | -47.28 | -47.28 | -45.03 | -38.06 | -26.43 | -34.09 |
Provision & Write-off of Bad Debts | 0.39 | 0.39 | 0.24 | -0.4 | -2.64 | -1.16 |
Other Operating Activities | 82.45 | -12.16 | -11.9 | -27.74 | 0.97 | -1.83 |
Change in Accounts Receivable | -45.75 | -45.75 | -5.82 | 16.12 | 151.98 | 96.35 |
Change in Inventory | 13.79 | 13.79 | -65.01 | -38.46 | -57.03 | 23.02 |
Change in Accounts Payable | -30.38 | -30.38 | -61.36 | -116.71 | -249.47 | -34.45 |
Change in Other Net Operating Assets | 1.75 | 1.75 | 3.82 | 7.79 | 4.71 | 733.42 |
Operating Cash Flow | 1,566 | 1,412 | 1,218 | 925.15 | 494.11 | 273.32 |
Operating Cash Flow Growth | 6.72% | 15.88% | 31.70% | 87.23% | 80.78% | -66.35% |
Capital Expenditures | -221.26 | -159.39 | -138.87 | -355.21 | -569.42 | -621.84 |
Sale of Property, Plant & Equipment | 0.28 | 0.55 | 0.2 | 0.06 | 0.08 | 0.04 |
Investment in Securities | -345 | - | 100 | 100 | -251.85 | -10 |
Other Investing Activities | 38.23 | 46.79 | 45.29 | 39.6 | 18.06 | 47.84 |
Investing Cash Flow | -527.75 | -112.06 | 6.62 | -215.55 | -803.14 | -583.96 |
Short-Term Debt Issued | - | - | - | - | - | 7.71 |
Total Debt Issued | - | - | - | - | - | 7.71 |
Short-Term Debt Repaid | - | - | - | - | - | -7.71 |
Long-Term Debt Repaid | - | -1.49 | -1.99 | -2.6 | -2.13 | - |
Total Debt Repaid | -1.49 | -1.49 | -1.99 | -2.6 | -2.13 | -7.71 |
Net Debt Issued (Repaid) | -1.49 | -1.49 | -1.99 | -2.6 | -2.13 | - |
Issuance of Common Stock | 33.24 | 6.75 | - | - | - | 1,606 |
Repurchase of Common Stock | - | - | - | - | - | -0.35 |
Common Dividends Paid | -552.67 | -349.4 | -137.92 | -91.95 | -91.95 | -244.6 |
Other Financing Activities | 0.87 | - | 9.41 | 20.7 | 15.24 | -4.37 |
Financing Cash Flow | -520.05 | -344.14 | -130.5 | -73.85 | -78.84 | 1,357 |
Foreign Exchange Rate Adjustments | -0.05 | -0.25 | -0.21 | 0.99 | -0.87 | -2.6 |
Net Cash Flow | 517.83 | 955.43 | 1,094 | 636.74 | -388.73 | 1,044 |
Free Cash Flow | 1,344 | 1,252 | 1,080 | 569.95 | -75.3 | -348.53 |
Free Cash Flow Growth | 2.31% | 16.02% | 89.41% | - | - | - |
Free Cash Flow Margin | 28.82% | 28.13% | 27.28% | 16.82% | -2.09% | -10.58% |
Free Cash Flow Per Share | 1.46 | 1.37 | 1.18 | 0.62 | -0.08 | -0.40 |
Cash Income Tax Paid | 432.6 | 400.54 | 391.52 | 343.76 | 450.78 | 463.03 |
Levered Free Cash Flow | 815.18 | 850.51 | 681.33 | 398.96 | -399.12 | -565.33 |
Unlevered Free Cash Flow | 815.18 | 850.51 | 681.33 | 398.96 | -399.12 | -565.02 |
Change in Working Capital | 43.12 | 43.12 | 2.66 | -68.84 | -265.76 | 456.99 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.